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Summary  The  hypothalamic-pituitary-adrenal  (HPA)  axis  plays  an  important  role  in  sleep.
Nevertheless,  the  association  of  sleep  and  its  24-h  organization  with  negative  feedback  con-
trol of  the  HPA  axis  has  received  limited  attention  in  population-based  studies.  We  explored
this association  in  493  middle-aged  persons  of  the  Rotterdam  Study,  a  large  population-based
study (mean  age  56  years,  standard  deviation:  5.3  years;  57%  female).  The  negative  feedback
of the  HPA  axis  was  measured  as  the  change  in  morning  saliva  cortisol  after  the  intake  of
0.25 mg  dexamethasone  the  night  before.  Actigraphy  allowed  us  to  measure  the  stability  andActigraphy;
Sleep;
Circadian  rhythm
fragmentation  of  the  activity  rhythm  and  to  estimate  total  sleep  time,  sleep  onset  latency  and
wake after  sleep  onset.  A  sleep  diary  kept  during  the  week  of  actigraphy  was  used  to  assess
self-reported  total  sleep  time,  sleep  onset  latency,  number  of  awakenings  and  perceived  sleep
quality. In  our  study,  enhanced  negative  feedback  of  the  HPA  axis  was  found  in  association  with
unstable  activity  rhythms  (B  =  0.106,  95%  conﬁdence  interval  (CI):  0.002;  0.210),  total  sleep
time (B  =  0.108,  95%CI:  0.001;  0.215)  and  poor  subjective  sleep  quality  (B  =  0.107,  95%CI:  0.009;
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0.206)  after  multivariate  adjustment.  These  results  indicated  that  the  24-h  organization,  dura-
tion and  experience  of  sleep  are  all  associated  with  the  negative  feedback  control  of  the  HPA
axis.
© 2015  Elsevier  Ltd.  All  rights  reserved.
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The  current  study  was  embedded  in  the  Rotterdam  Study,  a
population-based  cohort  of  middle-aged  and  elderly  inhabi-. Introduction
he  hypothalamic-pituitary-adrenal  (HPA)  axis  determines
he  stress  response  of  humans  as  it  regulates  the  release
f  cortisol  by  a  negative  feedback  control  (Dedovic  et  al.,
009).  Cortisol  shows  a  typical  diurnal  pattern  with  peaks
hen  stress  is  increased.  The  diurnal  pattern  is  regulated  by
he  suprachiasmatic  nucleus  (SCN),  the  body’s  central  pace-
aker,  which  is  responsible  for  the  overall  co-ordination  of
he  HPA  axis  and  synchronizing  the  time  of  day  and  neuroen-
ocrine  output  (Buijs  et  al.,  2003).
The  HPA  axis  plays  an  important  role  in  the  regula-
ion  of  sleep  (Buckley  and  Schatzberg,  2005).  However,
esearch  on  the  association  of  sleep  parameters  with  cor-
isol  secretion  is  not  consistent  (Elder  et  al.,  2014).  In
opulation-based  studies,  it  has  been  found  that  saliva
wakening  cortisol  was  not  associated  with  sleep  quantity
nd  quality  in  healthy  middle-aged  adults  (Zhang  et  al.,
011),  and  that  cortisol  levels  in  urine  were  not  associ-
ted  with  objective  sleep  duration  (Rao  et  al.,  2013).  In
ontrast,  others  have  observed  that  self-reported  sleep
uration  and  disturbances  were  associated  with  the  diur-
al  slope  in  cortisol  secretion  in  the  population  (Kumari
t  al.,  2009b).  None  of  these  studies,  however,  assessed
xperimentally  induced  activation  of  the  HPA-axis.  Cortisol
evels  can  be  manipulated  experimentally  by  performing  a
ehavioral  stress  test.  A  recent  publication  found  that  sleep
eprivation  was  associated  with  both  elevated  resting  cor-
isol  and  an  exaggerated  cortisol  response  after  the  Trier
ocial  Stress  Test  (Minkel  et  al.,  2014).  Cortisol  levels  can
lso  be  manipulated  pharmacologically  to  assess  the  func-
ioning  of  the  HPA  axis.  Results  of  studies  which  assessed
he  HPA  axis  after  pharmacological  manipulation  in  relation
o  sleep  are  also  mixed;  poor  sleep  can  lead  to  increased
ctivity  of  the  HPA  axis,  for  example  in  chronic  insomni-
cs  (Vgontzas  et  al.,  2001).  However,  self-rated  sleep  was
ot  related  to  cortisol  levels  after  dexamethasone  intake
n  a  combined  dexamethasone/corticotrophin-releasing-
ormone  (CRH)  test  (Hori  et  al.,  2011),  nor  were  sleep
isorders  (Lattova  et  al.,  2011).  Research  has  been  com-
licated  by  the  use  of  objective  versus  subjective  measures
f  sleep  in  different  studies  (Rao  et  al.,  2013).  In  addition,
oth  the  HPA  axis  and  sleep  behaviors  are  affected  by  stress.
owever,  most  studies  on  sleep  and  the  function  of  the  HPA
xis  have  been  done  in  the  laboratory,  and  rarely  in  the  home
ituation.  This  itself  might  affect  hormone  regulation,  which
ould  further  complicate  the  interpretation  and  generaliz-
bility  of  the  results.  In  addition,  sleep  and  cortisol  secretion
oth  have  strong  circadian  rhythms,  which  could  affect  the
ssociation  between  sleep  and  the  HPA  axis  (Buckley  and
chatzberg,  2005).  However,  not  much  is  known  about  the
4-h  organization  of  rest  activity  rhythms  in  reference  to
he  negative  feedback  of  the  HPA  axis  in  population-based
amples.
t
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wIn  the  current  study  we  assessed  the  negative  feedback  of
he  HPA  axis  with  a  very  low-dose  dexamethasone  suppres-
ion  test  (DST).  The  DST  is  speciﬁcally  designed  to  measure
he  negative  feedback  of  the  HPA  axis  and  has  mostly  been
sed  in  clinical  populations.  Initially,  assessment  of  the  neg-
tive  feedback  of  the  HPA  axis  was  developed  to  diagnose
ushing’s  disease  (Lindholm,  2014),  but  it  has  also  been
roposed  as  a  biomarker  for  psychiatric  diseases  (Arana
t  al.,  1985).  Diminished  negative  feedback  of  the  HPA  axis
as  been  found  in  melancholic  depression,  eating  disor-
ers  and  alcoholism,  while  in  contrast  an  enhanced  negative
eedback  has  been  associated  with  posttraumatic  stress  dis-
rder,  stress-related  bodily  disorders  and  chronic  fatigue
yndrome  (Ehlert  et  al.,  2001).  Within  the  general  popula-
ion  a  dose  of  1  mg  dexamethasone,  which  is  comparable  to
hat  applied  in  clinical  populations,  would  suppress  saliva
ortisol  almost  completely  in  all  persons  (Huizenga  et  al.,
998b).  Therefore  we  implemented  a  very  low-dose  DST  to
ssess  the  effect  of  0.25  mg  of  dexamethasone  on  cortisol
n  saliva.  A  dose  of  0.25  mg  dexamethasone  has  been  sug-
ested  for  a  more  informative  assessment  of  the  sensitivity
f  the  HPA  axis  feedback  in  healthy  adults  (Huizenga  et  al.,
998b).  We  speciﬁcally  tested  the  level  of  cortisol  after
 very  low-dose  of  dexamethasone  controlled  for  baseline
ortisol.
We  explored  whether  the  24-h  organization  of  the  activ-
ty  rhythm,  objective  and  subjective  sleep  parameters,  and
erceived  sleep  quality  were  related  with  the  negative
eedback  control  of  the  HPA  axis  in  the  general  popula-
ion  by  conducting  an  experiment  with  a very  low-dose  DST.
nhanced  negative  feedback  of  the  HPA  was  measured  as
he  reduction  in  morning  cortisol  after  a  low  dose  of  dexa-
ethasone  the  prior  evening.  Both  sleep  and  cortisol  have
 strong  circadian  organization,  therefore  we  hypothesized
hat  disturbed  24-h  activity  rhythms  were  related  with  the
egative  feedback  control  of  the  HPA  axis.  Results  for  the
ssociation  of  sleep  with  the  negative  feedback  control  have
een  mixed;  to  our  knowledge,  objectively  measured  habit-
al  sleep  has  only  been  studied  in  relation  to  the  negative
eedback  control  of  the  HPA  axis  in  adolescents  (Pesonen
t  al.,  2014).  Lastly,  we  expected  subjective  sleep  quality
o  be  associated  with  the  feedback  of  the  HPA  axis.
. Methods
.1.  Study  populationants  of  Rotterdam,  the  Netherlands  (Hofman  et  al.,  2013).
n  2006,  a  new  cohort  with  inhabitants  aged  45  and  over
as  added  (RSIII-1).  The  study  was  conducted  in  accordance
ith  the  guideline  proposed  in  the  World  Medical  Association
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aSleep,  24-h  rhythms,  and  dexamethasone  suppression  
Declaration  of  Helsinki  and  approved  by  the  medical  ethics
committee  according  to  the  Wet  Bevolkingsonderzoek  ERGO
(Population  Study  Act  Rotterdam  Study),  executed  by  the
Ministry  of  Health,  Welfare  and  Sports  of  the  Netherlands.
Written  informed  consent  was  obtained  from  all  partici-
pants.
All  participants  in  RSIII-1  were  invited  for  the  very  low-
dose  DST  at  the  baseline  assessment.  Of  1822  persons
(response  rate  63.9%)  a  valid  very  low-dose  DST  was  avail-
able  after  the  exclusion  of  persons  with  incomplete  data
(n  =  58),  persons  who  used  corticosteroids  (n  =  3),  or  invalid
timing  of  sampling  (n  =  59).  Of  these  1822  persons,  627
persons  were  invited  for  the  actigraphy  study,  43  persons
refused  to  participate  (6.9%).  In  17  persons  actigraphic
recordings  did  not  consist  of  4  consecutive  days  and  nights,
in  16  persons  recordings  were  collected  within  a  week  of
daylight  saving  time,  and  in  58  persons  the  actiwatch  mal-
functioned.  In  total,  493  persons  remained  for  analyses.
2.2.  Assessment  of  the  very  low-dose
dexamethasone  suppression  test
For  the  very  low  DST  participants  were  asked  to  collect  a
saliva  sample  at  0800  h  at  day  1,  take  a  very  low  dose  of
dexamethasone  (0.25  mg,  PO)  at  2300  h  at  day  1,  and  col-
lect  saliva  again  at  0800  h  at  day  2.  Sampling  times  were
kept  equal  for  all  participants  to  prevent  large  individ-
ual  differences  in  the  time  between  dexamethasone  intake
and  cortisol  sampling.  Saliva  samples  were  collected  using
Salivette  sampling  devices  (Sarstedt,  Nümbrecht,  Germany).
Participants  received  oral  and  written  instructions  about
the  use  of  the  sampling  device.  In  addition,  they  were
asked  not  to  eat  or  brush  their  teeth  15  min  before  the
collection  of  the  samples  and  to  report  the  exact  date
and  time  of  the  sampling.  Samples  were  stored  at  −80 ◦C
until  they  were  analyzed  at  the  laboratory  of  Biopsychol-
ogy,  Technical  University  of  Dresden,  Germany.  Salivary
cortisol  concentrations  were  measured  using  a  commercial
immunoassay  with  chemiluminescence  detection  (CLIA;  IBL
Hamburg,  Hamburg,  Germany),  further  details  have  been
described  elsewhere  (N.  Direk,  M.J.H.J.  Dekker,  A.I.  Luik,
C.  Kirschbaum,  Y.B.  De  Rijke,  A.  Hofman,  W.J.  Hoogendijk,
H.  Tiemeier,  unpublished  observations).
2.3.  Assessment  of  the  24-h  activity  rhythm  and
sleep
Actigraphy  allowed  us  to  measure  the  24-h  activity  rhythm
(Tobler  and  Borbely,  1993;  De  Souza  et  al.,  2003)  and  to  esti-
mate  sleep  parameters  objectively  (Kushida  et  al.,  2001).
All  participants  wore  an  actigraph  around  the  non-dominant
wrist  (Actiwatch  model  AW4,  Cambridge  Technology  Ltd)
continuously  for  7  consecutive  days  and  nights,  the  actigraph
was  only  to  be  removed  while  bathing.  Actigraphs  measured
in  30-s  epochs  (Kushida  et  al.,  2001).  Recordings  had  to  con-
sist  of  at  least  96  h.  All  24-h  periods  with  more  than  three
continuous  hours  missing  were  excluded  from  the  analyses  to
prevent  a  time-of-day  effect.  The  average  duration  of  the
actigraphy  recordings  was  138  h  (standard  deviation  (SD):
14  h).
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Activity  rhythms  were  quantiﬁed  using  non-parametric
ndicators  (Van  Someren  et  al.,  1996;  Luik  et  al.,  2013)
o  describe  the  rhythm  without  making  strong  assumptions
bout  the  shape  of  the  rhythm  (Van  Someren,  2011).  Two
ariables  were  calculated  to  assess  the  24-h  activity  rhythm:
he  interdaily  stability  and  the  intradaily  variability.  The
nterdaily  stability  indicates  the  stability  of  the  rhythm,
.e.  the  extent  to  which  the  proﬁles  of  individual  days
esemble  each  other.  Intradaily  variability  quantiﬁes  how
ragmented  the  rhythm  is  relative  to  the  overall  variance.  It
s  based  on  hourly  values  and  reﬂects  transitions  of  relatively
ong  periods  of  rest  and  activity;  more  frequent  alterations
etween  an  active  and  an  inactive  state  lead  to  a  higher
ntradaily  variability.
We  also  used  the  actigraphy  recordings  to  estimate  sleep
arameters.  Actigraphy  is  considered  a reliable  estimator
f  sleep  parameters  such  as  total  sleep  time  (Ancoli-Israel
t  al.,  2003).  We  used  a validated  algorithm  (Kushida  et  al.,
001) to  calculate  total  sleep  time,  sleep  onset  latency  and
ake  after  sleep  onset  using  the  actigraphy  (van  den  Berg
t  al.,  2008;  Luik  et  al.,  2013).
Total  sleep  time,  sleep  onset  latency  and  number  of
wakenings  were  also  self-rated  by  the  participant  using
 sleep  diary  which  was  kept  during  the  week  of  actig-
aphy.  Values  were  averaged  over  the  7  nights.  Perceived
leep  quality  was  evaluated  with  this  same  sleep  diary;
articipants  answered  3  dichotomous  questions  about  their
leep  quality.  Perceived  sleep  quality  indicates  the  aver-
ge  of  the  summed  and  weighted  questions  over  7  nights
range  0—7).
.4.  Assessment  of  covariates
e  a  priori  selected  sex,  age,  partnership,  education,
mployment  status,  exercise,  body  mass  index  (BMI),  cof-
ee  use,  alcohol  use,  current  smoking,  activities  of  daily
iving  (ADL),  cognitive  status,  depressive  symptoms,  dia-
etes  mellitus,  possible  apnea  and  use  of  sleep  medication,
sycholeptics  and/or  psychoanaleptics,  time  of  cortisol
ampling,  habitual  wake  up  time,  and  the  time  differ-
nce  between  sleep  measurements  and  cortisol  sampling
s  covariates  based  on  previous  literature  (Vreeburg  et  al.,
009;  Luik  et  al.,  2013).  During  a  home  interview  all  partic-
pants  were  asked  about  a  partner,  education,  employment
tatus,  exercise,  smoking,  ADL,  possible  apnea  and  med-
cation  use.  Exercise  indicates  whether  the  participants
racticed  any  sports  on  the  basis  of  a  self-report  question-
aire  item.  ADL  was  evaluated  with  the  Stanford  Health
ssessment  Questionnaire  to  indicate  health  status  (Fries
t  al.,  1980).  Cognitive  status  was  measured  with  the
ini  Mental  State  Exam  (MMSE)  (Folstein  et  al.,  1975).  We
sed  the  Center  for  Epidemiologic  Studies-Depression  (CES-
)  scale  to  measure  depressive  symptoms  (Radloff,  1977;
eekman  et  al.,  1997).  Diabetes  mellitus  was  determined
uring  the  center  visit  on  the  basis  of  fasting  or  non-fasting
lucose  levels  in  combination  with  medical  records.  Possible
pnea  was  assessed  with  two  questions  from  the  Pittsburgh
leep  Quality  Index  (Buysse  et  al.,  1989).  We  considered
pnea  possible  when  participants  reported  (1)  loud  snoring
t  least  two  nights  per  week  and  at  least  occasional  respi-
atory  pauses  or  (2)  respiratory  pauses  during  sleep  with  a
2 A.I.  Luik  et  al.
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Table  1  Population  characteristics  (n  =  493).
Demographics
Female,  %  57.2
Age, years  55.58  ±  5.34
Partnership,  %  81.3
Education,  %
Low  8.9
Intermediate  66.5
High 23.1
Employment,  %  56.6
Health  indicators
Exercising,  %  59.8
Body  mass  index  (BMI),  kg/m2 27.60  ±  4.28
Coffee  use,  cups  per  day  0.96  ±  0.84
Alcohol  use,  units  per  week  6.09  ±  8.00
Current  smoking,  %  25.8
Activities  of  daily  living,  score  0.15  ±  0.29
Cognitive  status,  score  28.11  ±  1.75
Depressive  symptoms,  score  5.87  ±  7.46
Diabetes  Mellitus,  % 8.3
Possible  Apnea,  % 26.4
Use  of  sleep  medication,  psycholeptics
and/or  psychoanaleptics,  %
21.1
Cortisol
Cortisol  in  saliva  before
dexamethasone  intake,  mmol/L
14.75  ±  8.65
Cortisol  in  saliva  after  dexamethasone
intake,  mmol/L
6.12  ±  7.13
Sampling  time  day  1,  clocktime  7:57  ±  0:42
Sampling  time  day  2,  clocktime  7:55  ±  0:33
Time  between  sleep  measurements
and  cortisol  sampling,  days
34.83  ±  25.21
24-h activity  rhythm
Interdaily  stability,  score  0.80  ±  0.10
Intradaily  variability,  score  0.39  ±  0.11
Duration  of  actigraphy,  h  137.72  ±  15.04
Actigraphic  sleep
Total  sleep  time,  h  6.31  ±  0.88
Sleep  onset  latency,  min  6.37  ±  2.44
Wake  after  sleep  onset,  min  68.67  ±  23.93
Self-rated  sleep
Total  sleep  time,  h  6.77  ±  0.95
Sleep  onset  latency,  min  17.90  ±  12.97
Number  of  awakenings,  score  1.48  ±  1.09
Actigraphic  habitual  wake  up  time,
clocktime
07:34  ±  0:53
Sleep  quality
310  
requency  of  at  least  1—2  nights  per  week  (Fogelholm  et  al.,
007).  Use  of  medication  was  based  on  self-report  during  the
ome  interview  and  in  the  sleep  diary.  Height  and  weight
ere  measured  without  shoes  and  heavy  clothing  during  a
enter  visit  to  calculate  the  BMI  (kg/m2).  Coffee  and  alco-
ol  use  were  the  number  of  units  consumed  per  day  after
8:00  h  in  the  week  of  actigraphy,  as  reported  in  a  daily
uestion  in  the  sleep  diary.  Time  of  cortisol  sampling  was
elf-reported  in  a  form  which  was  enclosed  with  the  saliva
ampling  devices.  Habitual  actigraphic  wake  up  time  was
veraged  over  the  actigraphy  period.
.5.  Statistical  analyses
e  assessed  the  associations  of  the  24-h  activity  rhythm
nd  sleep  parameters  with  saliva  cortisol  levels  after  the
ntake  of  0.25  mg  dexamethasone  with  linear  regression
n  successive  models.  First,  we  studied  the  associations
djusting  for  baseline  cortisol,  sex  and  age.  Second,  we
an  models  which  we  adjusted  for  baseline  cortisol,  sex,
ge,  partnership,  education,  employment  status,  BMI,  alco-
ol  use,  current  smoking,  ADL,  cognitive  status,  diabetes
ellitus  and  use  of  sleep  medication,  psycholeptics  and/or
sychoanaleptics,  habitual  wake  up  time,  and  the  time  dif-
erence  between  sleep  measurements  and  cortisol  sampling.
astly,  we  ran  a  model  in  which  we  adjusted  the  analy-
es  additionally  for  depressive  symptoms  to  test  whether
ffects  were  confounded  by  mental  health.  We  included
he  a  priori  selected  covariate  in  the  model  if  the  covari-
te  predicted  the  24-h  activity  rhythm  or  sleep  (p  <  0.05)
r  if  it  changed  the  effect  estimate  of  the  main  deter-
inants  by  more  than  10%.  Exercise,  coffee  use,  possible
pnea  and  time  of  cortisol  sampling  did  not  meet  either  of
hese  criteria.  Next,  we  assessed  whether  sex  and  medi-
ation  modiﬁed  the  associations  of  24-h  rhythms  and  sleep
ith  cortisol.  We  additionally  analyzed  the  association  of
he  24-h  activity  rhythm  and  sleep  parameters  with  the
aliva  cortisol  level  before  and  after  dexamethasone  intake
ithout  adjustment  for  baseline  cortisol  in  all  three  mod-
ls  for  the  comparison  of  our  results  with  results  from  the
lassical  DST.  In  the  classical  DST,  only  cortisol  after  dexa-
ethasone  intake  is  assessed,  instead  of  the  change  in
ortisol  levels  before  and  after  intake.  All  analyses  were  per-
ormed  using  SPSS  Statistics  (version  21,  IBM  Corp.,  Somers,
Y  USA).
Saliva  cortisol  levels  were  natural-log  transformed  due
o  the  non-normal  distribution.  All  24-h  activity  rhythm
nd  sleep  indicators  were  winsorized  at  4  standard  devi-
tions  to  the  mean.  We  used  a  Box—Cox  transformation
Box  and  Cox,  1964;  Osborne,  2010)  to  obtain  normally  dis-
ributed  values  for  interdaily  stability  (  =  7.0),  intradaily
ariability  (  =  3.9),  actigraphic  sleep  onset  latency  (  =  0.1),
ctigraphic  wake  after  sleep  onset  (  =  0.4),  self-rated  sleep
nset  latency  (  =  0.3),  self-rated  number  of  awakenings
  =  0,  natural  log  transformation)  and  subjective  sleep
uality  (  =  5.3).  All  24-h  activity  rhythm  and  sleep  indi-
ators  were  standardized  to  facilitate  the  interpretation.
he  number  of  missing  values  for  the  covariates  was  gener-
lly  low  (alcohol  use  0.4%,  ADL  6.3%,  cognitive  status  2.0%,
epressive  symptoms,  0.2%).  Missing  values  in  quantitative
redictors  were  replaced  by  the  median  (Schafer,  1999).
P
T
t
l
iPerceived  sleep  quality,  score  5.35  ±  1.68
Values are stated as mean ± standard deviation or percentage.
. Results
opulation  characteristics  (N  =  493)  are  presented  in  Table  1.
he  mean  age  of  our  sample  was  55.6  years  (standard  devia-
ion  (SD):  5.34)  and  57%  was  female.  Average  saliva  cortisol
evels  were  14.7  mmol/L  (SD:  8.65)  in  the  morning  before  the
ntake  of  dexamethasone  and  6.1  mmol/L  (SD:  7.13)  in  the
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Table  2  Correlations  of  cortisol  in  saliva,  24-h  activity  rhythms,  and  sleep  (N  =  493).
1  2  3  4  5  6  7  8  9  10  11
Cortisol
1.  Cortisol  in  saliva
before  dexamethasone
intake
—
2. Cortisol  in  saliva  after
dexamethasone  intake
0.40 —
Circadian  rhythm
3.  Interdaily  stability  0.12  0.10  —
4. Intradaily  variability  −0.09  −0.09  −0.60  —
Actigraphic  sleep
5. Total  sleep  time  −0.04  −0.05  0.33  −0.31  —
6. Sleep  onset  latency  −0.06  −0.02  −0.27  0.34  −0.46  —
7. Wake  after  sleep
onset
−0.10  −0.11  −0.16  0.23  −0.17  0.74  —
Self-rated  sleep
8.  Total  sleep  time  −0.03  −0.05  0.09  −0.13  0.41  −0.04  0.09  —
9. Sleep  onset  latency  −0.01  −0.05  0.00  0.01  0.10  0.14  0.21  −0.26  —
10. Number  of
awakenings
−0.11  −0.10  −0.01  0.01  0.15  0.05  0.26  −0.17  0.25  —
Sleep quality
11.  Perceived  sleep
quality
0.11  0.18  0.07  −0.05  0.01  −0.04  −0.06  0.33  −0.30  −0.35  —
Bold indicates p < 0.05. Pearson correlation coefﬁcients. All cortisol levels were natural-log transformed, interdaily stability, intradaily
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0variability, actigraphic sleep onset latency, actigraphic wake afte
awakenings and perceived sleep quality were Box—Cox transforme
morning  after  the  intake  of  0.25  mg  dexamethasone.  Par-
ticipants  slept  on  average  6.3  h  (SD:  0.88)  according  to  the
actigraphy,  self-rated  total  sleep  time  was  6.8  h  (SD:  0.95)
on  average.  On  average,  the  week  of  actigraphy,  in  which  the
sleep  variables  were  also  self-reported  by  means  of  a  sleep
diary,  took  place  one  month  (35  days,  SD:  25.21)  before  the
very  low-dose  DST.
Table  2  shows  the  correlations  between  saliva  corti-
sol  levels,  the  24-h  activity  rhythm  and  sleep  parameters.
Cortisol  levels  before  and  after  dexamethasone  intake  cor-
related  moderately  with  each  other  (r  =  0.40,  p  <  0.01)  and
minimally  with  depressive  symptoms  (r  =  −0.10,  p  =  0.024
and  r  =  −0.09,  p  = 0.036  respectively).  Parameters  of  the
24-h  activity  rhythm  correlated  substantially  with  each
other  (r  =  −0.60,  p  <  0.01).  Similarly,  actigraphic  sleep  onset
latency  and  actigraphic  wake  after  sleep  onset  (r  =  0.74,
p  <  0.01)  correlated  highly.
Next,  we  explored  the  stability  and  fragmentation  of  the
24-h  activity  rhythm  with  saliva  cortisol  after  dexametha-
sone  intake  (adjusted  for  baseline  cortisol),  see  Table  3.
A  more  stable  rhythm  was  associated  with  higher  levels
of  saliva  cortisol  after  dexamethasone  in  the  basic  model
(B  =  0.132,  95%  conﬁdence  interval  (CI):  0.032;  0.233).
This  association  remained  after  multivariate  adjustment
(B  =  0.106,  95%CI:  0.002;  0.210)  including  adjustment  for
depressive  symptoms  (B  =  0.106,  95%CI:  0.002;  0.210).  A
more  fragmented  rhythm  was  associated  with  lower  saliva
cortisol  after  dexamethasone  in  the  basic  model  (B  =  −0.102,
95%CI:  −0.203;  0.000).  This  association  was  attenuated
m
a
dp onset, self-rated sleep onset latency and self-rated number of
fter  multivariate  adjustment  (B  =  −0.073,  95%CI:  −0.178;
.032),  most  likely  due  to  strong  confounding  of  wake  up
ime  (B  =  −0.196,  95%CI:  −0.306;  −0.086).
In  addition,  we  assessed  actigraphically  measured  sleep
arameters,  as  well  as  self-rated  sleep  parameters  in  rela-
ion  to  saliva  cortisol  levels  after  dexamethasone  intake
ontrolled  for  baseline  cortisol  (Table  3).  Total  sleep  time
as  related  to  saliva  cortisol  after  dexamethasone,  but
nly  after  multivariate  adjustment  (B  =  0.108,  95%CI:  0.001;
.215).  Stepwise  analyses  showed  that  this  association  was
ffected  most  by  the  confounding  of  actigraphic  wake-up
ime  (results  not  presented).  Further  adjustment  for  depres-
ive  symptoms  did  not  change  the  effect  estimate  (B  =  0.108,
5%CI:  0.001;  0.215).  Other  sleep  parameters  were  not
elated  to  saliva  cortisol  after  dexamethasone  intake,  inde-
endent  of  measurement  method.
We  also  studied  whether  perceived  sleep  quality  was
ssociated  with  saliva  cortisol  after  dexamethasone  intake
Table  3).  In  all  models,  a  better  perceived  sleep  qual-
ty  was  associated  with  higher  levels  of  saliva  cortisol
fter  dexamethasone  intake  (basic  model:  B  =  0.108,  95%CI:
.011;  0.205,  and  multivariate  model:  B  =  0.107,  95%CI:
.009;  0.206).  Further  adjustment  for  depressive  symptoms
hanged  the  effect  estimate  marginally  (B  =  0.118,  95%CI:
.014;  0.222).Next,  we  studied  whether  sex  and  the  intake  of  sleep
edication,  psycholeptics  or  psychoanaleptics  modiﬁed  the
ssociations  of  the  24-h  rhythm  and  sleep  with  cortisol  after
examethasone  intake.  Signiﬁcant  interaction  effects  of  sex
212  A.I.  Luik  et  al.
Table  3  Associations  of  the  24-h  activity  rhythm  and  sleep  with  saliva  cortisol  after  dexamethasone  intake  when  adjusted  for
baseline cortisol  (N  =  493).
Cortisol  in  saliva  after  dexamethasone  intake
Basic  model  Multivariate  model
B  95%CI  B  95%CI
24-h  activity  rhythm
Interdaily  stability  0.132  0.032;  0.233  0.106  0.002;  0.210
Intradaily variability  −0.102  −0.203;  0.000  −0.073  −0.178;  0.032
Actigraphic sleep
Total  sleep  time 0.034 −0.063;  0.130 0.108  0.001;  0.215
Sleep onset  latency −0.089 −0.253;  0.074 −0.087 −0.254;  0.079
Wake after  sleep  onset  −0.087  −0.189;  0.014  −0.074  −0.179;  0.031
Self-rated sleep
Total  sleep  time  −0.038  −0.132;  0.055  0.012  −0.086;  0.110
Sleep onset  latency  −0.011  −0.103;  0.081  0.004  −0.090;  0.098
Number of  awakenings  −0.017  −0.110;  0.077  −0.028  −0.122;  0.066
Sleep quality
Perceived  sleep  quality  0.108  0.011;  0.205  0.107  0.009;  0.206
Bold indicates p < 0.05. CI: conﬁdence interval. Linear regression analyses. Cortisol levels were natural-log transformed, interdaily
stability, intradaily variability, actigraphic sleep onset latency, actigraphic wake after sleep onset, self-rated sleep onset latency, self-
rated number of awakenings and perceived sleep quality were Box—Cox transformed to obtain a normal distribution. All activity rhythm
and sleep variables were standardized. The basic model was adjusted for baseline cortisol, sex and age. The multivariate model was
adjusted for baseline cortisol, sex, age, partnership, education, employment, body mass index, alcohol use, smoking, activities of daily
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eliving, cognitive status, diabetes mellitus, use of sleep medication
wake up time and time difference between sleep measurements a
ere  found  on  the  associations  of  interdaily  stability  with
ortisol  after  dexamethasone  (p  =  0.049)  and  on  the  associ-
tion  of  total  sleep  time  with  cortisol  after  dexamethasone
p  = 0.032).  In  men  interdaily  stability  and  cortisol  after
examethasone  (n  =  211,  B  =  0.192,  95%CI:  0.036;  0.348)
ere  more  strongly  associated  than  in  women  (n  =  282,
 =  0.024,  95%CI:  −0.119;  0.166).  Likewise,  total  sleep  time
nd  cortisol  after  dexamethasone  were  more  strongly  asso-
iated  in  men  (B  =  0.186,  95%CI:  0.032;  0.339)  than  in  women
B  =  0.029,  95%CI:  0.123;  −0.181).  No  signiﬁcant  interactions
ere  found  for  an  effect  of  medication  on  any  of  the  asso-
iations.
Last,  we  present  the  associations  of  the  24-h  activity
hythm  and  sleep  parameters  with  saliva  cortisol  before
examethasone  intake  and  after  dexamethasone  intake  not
djusting  for  baseline  cortisol  (see  Appendix,  tables  A1
nd  A2).  Persons  with  more  stable  rhythms  had  higher
evels  of  cortisol  both  before  and  after  dexamethasone
ntake  (B  =  0.064,  95%CI:  0.005;  0.123,  B  =  0.149,  95%CI:
.038;  0.260  respectively).  Self-rated  number  of  awakenings
ere  associated  with  cortisol  before  dexamethasone  intake
fter  multivariate  adjustment  (B  =  −0.054,  95%CI:  −0.106;
0.001),  whereas  they  were  not  related  to  saliva  corti-
ol  after  dexamethasone  intake  (B  =  −0.065,  95%CI:  −0.166;
.035).  In  addition,  in  persons  with  a  worse  perceived  sleep
uality  no  changes  were  observed  in  saliva  cortisol  before
examethasone  (B  =  0.038,  95%CI:  −0.018;  0.094).  However,
n  those  with  a  worse  sleep  quality  cortisol  after  dexameth-
sone  was  lowered  (B  =  0.133,  95%CI:  0.028;  0.239)  after
ultivariate  adjustment.  Associations  of  cortisol  after  dexa-
ethasone  had  marginally  increased  effects  sizes  when  they
ere  not  adjusted  for  baseline  cortisol,  but  were  largely
f
o
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wedication prescribed for the nervous system, actigraphic habitual
ortisol sampling.
imilar  to  the  associations  that  were  adjusted  for  baseline
ortisol.
. Discussion
ur  study  demonstrated  that  a  lower  stability  of  the  24-h
ctivity  rhythm  is  associated  with  enhanced  negative  feed-
ack  of  cortisol  in  the  HPA  axis.  Similarly,  a poor  perceived
leep  quality  was  related  to  enhanced  negative  feedback.
otal  sleep  time  was  associated  with  cortisol  after  dexa-
ethasone  only  when  controlled  for  wake-up  time.  Total
leep  time  and  perceived  sleep  quality  were  associated
niquely  with  cortisol  levels  after  the  intake  of  dexameth-
sone,  these  sleep  characteristics  were  not  associated  with
ortisol  before  the  intake  of  dexamethasone.
The  stability  of  the  24-activity  rhythm  was  associated
ith  the  change  in  saliva  cortisol  after  intake  of  0.25  mg
examethasone.  There  are  several  explanations  possible  for
he  association  of  less  stable  rhythms  with  enhanced  nega-
ive  feedback  of  the  HPA  axis.  First,  a  deterioration  of  the
CN  may  underlie  both  less  stable  activity  rhythms  as  well
s  an  enhanced  negative  feedback  control  of  the  HPA  axis.  A
eteriorated  SCN  can  result  in  problems  in  integrating  inter-
al  and  external  time  cues  (Hofman  and  Swaab,  2006),  which
an  lead  to  unstable  and  fragmented  rhythms  and  possibly
isturbances  in  the  cortisol  rhythm  (Clow  et  al.,  2010).  How-
ver,  research  has  suggested  that  CRH,  which  is  released
rom  the  hypothalamus,  is  the  key  circadian  alerting  signal
f  the  HPA  axis  instead  of  cortisol  (Buckley  and  Schatzberg,
005).  Second,  the  association  of  the  stability  of  the  rhythm
ith  the  negative  feedback  of  the  HPA  axis  could  be  due  to
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depressive  symptoms;  cortisol  after  dexamethasone  intake
has  been  suggested  as  a  biomarker  for  depression  (Arana
et  al.,  1985).  However,  while  depression  has  been  related
with  more  disturbed  circadian  rhythms  (Germain  and  Kupfer,
2008),  it  has  mostly  been  related  to  a  diminished  negative
feedback  of  the  HPA  instead  of  an  enhanced  negative  feed-
back.  This  is  not  consistent  with  our  results  as  we  ﬁnd  that
less  stable  rhythms  are  associated  with  enhanced  negative
feedback  of  the  HPA  axis.  Also,  adjustment  for  depressive
symptoms  did  not  change  the  association  between  the  sta-
bility  of  the  rhythm  and  the  negative  feedback  control  in
the  present  study.  Associations  in  the  same  direction  as  in
the  present  study  have  been  reported  for  other  disorders
such  as  post-traumatic  stress  disorder  (Ehlert  et  al.,  2001)
and  job-related  exhaustion  (Menke  et  al.,  2014).  The  asso-
ciation  of  job-related  exhaustion  with  negative  enhanced
feedback  has  been  explained  by  glucocorticoid  receptor
hypersensitivity  accompanied  by  changes  in  GR  induced
gene  expression.  Possibly,  the  association  of  less  stable
rhythms  with  enhanced  negative  feedback  follows  a  similar
mechanism,  further  studies  are  needed  to  test  this  hypothe-
sis.  Third,  less  stable  activity  rhythms  may  directly  inﬂuence
cortisol  levels.  Possibly,  the  association  of  a  more  stable
rhythm  and  lower  cortisol  levels  can  be  explained  by  better
persistence  of  a  rapidly  rising  cortisol  awakening  response,
despite  a  low  dose  of  dexamethasone,  in  those  maintaining
a  more  stable  activity  rhythm.  Unstable  rhythms  may  result
in  more  awakenings  or  more  ﬂuctuations  which  are  phys-
ical  and  psychological  stressors  that  can  increase  cortisol
levels  (Kudielka  and  Wust,  2010).  These  increased  corti-
sol  levels  might  need  higher  doses  of  dexamethasone  to  be
suppressed.  In  our  study  we  did  not  ﬁnd  an  association  of
wake  after  sleep  onset  or  fragmented  rhythms  suggesting
that  awakenings  are  not  key  in  the  association  of  unsta-
ble  rhythms  with  enhanced  negative  feedback  of  the  HPA
axis.  Fourth,  previous  research  suggests  that  the  associa-
tion  between  the  stability  of  the  rhythm  and  the  negative
feedback  control  is  bi-directional  (Buckley  and  Schatzberg,
2005).  Thus,  a  less  adaptive  HPA  axis  could  also  lead  to  more
unstable  rhythms.  Stability  of  the  24-h  rhythms  can  be  highly
dependent  on  amenable  behaviors.  Less  regulation  of  the
HPA  axis  might  lead  to  less  regulated  behaviors,  including
less  habituated  sleep  and  wake  times.
In  our  sample,  total  sleep  time  was  related  to  saliva
cortisol  levels  after  the  intake  of  a  very  low-dose  of  dexa-
methasone.  This  ﬁnding  was  dependent  of  the  measurement
method  of  sleep;  it  was  only  found  when  total  sleep  time
was  assessed  objectively  with  actigraphy.  Previous  results
have  been  mixed.  Most  associations  of  sleep  with  cor-
tisol  were  found  in  clinical  samples,  i.e.  in  insomniacs
(Vgontzas  et  al.,  2001),  or  after  experimental  manipula-
tion  of  sleep,  i.e.  after  sleep  deprivation  (Minkel  et  al.,
2014).  Population-based  studies  have  not  found  associa-
tions  between  objectively  assessed  sleep  and  cortisol  (Zhang
et  al.,  2011;  Rao  et  al.,  2013),  however  these  cortisol  lev-
els  were  not  experimentally  manipulated.  In  line  with  this,
we  also  found  that  indeed  total  sleep  time  was  not  associ-
ated  with  cortisol  levels  before  dexamethasone  intake.  The
discrepancy  between  cortisol  levels  before  and  after  dexa-
methasone  intake  could  be  explained  multiple  ways.  First,
sleep  may  only  affect  the  glucocorticoid  receptor  medi-
ated  negative  feedback,  which  is  the  mechanism  mainly
s
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nﬂuenced  by  the  intake  of  dexamethasone,  and  no  other
echanisms  involved  in  cortisol  production.  Second,  a  rapid
abituation  of  the  production  of  cortisol  to  sleep  distur-
ances  has  been  reported  (Spath-Schwalbe  et  al.,  1991),
ossibly  this  habituation  only  affects  certain  aspects  of  the
unctioning  of  the  HPA  axis.
Poor  perceived  sleep  quality  was  associated  with
nhanced  negative  feedback  of  the  HPA  axis.  This  associ-
tion  is  unique  for  the  negative  feedback  control  of  the
PA  axis  since  the  association  was  only  observed  with  corti-
ol  after  dexamethasone  intake  and  not  with  cortisol  levels
efore  dexamethasone  intake.  Altered  HPA-axis  activity
as  been  reported  in  stress-related  conditions,  for  exam-
le  after  acute  induced  stress  (Kudielka  and  Wust,  2010),
fter  prenatal  stress  (Painter  et  al.,  2012)  and  in  stress
isorders  (de  Kloet  et  al.,  2006).  Stress  could  also  impact
ow  persons  experience  their  sleep  quality.  More  gener-
lly,  perceived  sleep  quality  may  be  a  marker  for  general
ocial,  psychological  or  physical  issues,  which  might  affect
ow  persons  react  to  pharmacologically  or  psychologically
nduced  stress.  Yet,  depressive  symptoms  could  not  explain
he  association  between  perceived  sleep  quality  and  the
egative  feedback  control  in  our  study.  This  is  in  line  with
he  normalization  of  cortisol  levels  in  depressed  patients
ndependent  of  their  sleep  quality  (Steiger  et  al.,  1989).
n  a  previous  population-based  study,  low  waking  salivary
ortisol  and  a  ﬂatter  slope  in  cortisol  secretion  were  associ-
ted  with  fatigue  (Kumari  et  al.,  2009a).  Possibly,  symptoms
uch  as  fatigue  represent  the  mechanism  which  underlies  the
ssociation  of  poor  perceived  sleep  quality  and  enhanced
egative  feedback  of  the  HPA  axis  in  the  present  study.
his  would  also  be  in  line  with  previously  described  asso-
iation  of  enhanced  negative  feedback  with  chronic  fatigue
yndrome  (Ehlert  et  al.,  2001) and  job-related  exhaustion
Menke  et  al.,  2014).
In  our  study,  the  associations  of  the  stability  of  the
hythm  and  total  sleep  time  with  cortisol  change  differed
y  sex.  It  has  been  demonstrated  that  men  exhibit  greater
aliva  responses  in  studies  with  social  stress  situations,  but
tudies  which  assessed  the  pharmacological  manipulation
f  cortisol  levels  did  either  demonstrate  no  sex  differences
r  a  decreased  feedback  sensitivity  in  women,  speciﬁcally
t  older  age  (Kudielka  and  Kirschbaum,  2005).  Our  results
ere  more  pronounced  in  men,  which  is  in  line  with  previ-
us  evidence  of  a  stronger  negative  feedback  in  men  than
omen.  The  use  of  0.25  mg  of  dexamethasone  might  have
een  too  low  to  trigger  a  response  in  the  middle-aged  and
lderly  women  of  our  sample  due  to  the  decreased  feedback
ensitivity  in  this  population.
Our  study  has  several  strengths.  First,  to  our  knowledge,
e  were  the  ﬁrst  to  assess  a  very  low-dose  DST  in  rela-
ion  to  sleep  in  a  population-based  study  in  middle-aged  and
lderly  persons  which  deals  with  the  generalizability  prob-
em  in  clinical  studies.  Second,  we  were  able  to  study  the
4-h  organization  of  the  activity  rhythm  as  persons  were
tudied  with  actigraphy  over  multiple  days.  And  last,  we
tudied  sleep  with  both  a  sleep  diary  and  actigraphy  over
he  same  period,  which  allowed  us  to  differentiate  between
ubjective  and  objective  measurements  of  sleep.  Never-
heless,  there  are  also  limitations  to  our  study.  First,  we
ssessed  the  effects  of  a  very  low-dose  dexamethasone  in  a
ample  of  middle-aged  and  elderly  persons.  Dexamethasone
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etabolism  has  been  suggested  to  alter  with  age  (Hunt
t  al.,  1989;  Lister  and  Sigalas,  2011).  Age  did  not  have  a  sig-
iﬁcant  confounding  inﬂuence  in  our  study,  but  we  must  be
areful  in  generalizing  these  results  to  younger  populations.
econd,  although  actigraphy  is  a  valid  estimator  of  sleep,  it
acks  the  precision  of  polysomnography  (Ancoli-Israel  et  al.,
003).  Third,  the  very  low-dose  DST  was  performed  at  home
y  the  participants  which  makes  is  susceptible  for  non-
ompliance.  However,  all  of  our  participants  participated
oluntarily  and  could  have  easily  withdrawn  from  partici-
ation.  In  other  population-based  studies  non-compliance
as  also  not  been  an  issue  (Remillard  et  al.,  1993;  Vreeburg
t  al.,  2009).  Fourth,  we  evaluated  the  effects  of  dexa-
ethasone  on  saliva  cortisol  levels.  It  has  been  suggested
hat  low  doses  of  dexamethasone  only  create  a  state  of
ow  brain  cortisol  which  leads  to  a  compensatory  increase
n  central  CRH  (Buckley  and  Schatzberg,  2005).  However,
e  were  not  able  to  assess  this  with  the  current  study.  In
ddition,  the  impact  of  0.25  mg  of  dexamethasone  has  been
ound  to  be  less  reproducible  in  saliva  cortisol  levels  than
n  serum  cortisol  levels  (Reynolds  et  al.,  1998).  The  suscep-
ibility  for  this  low  dose  of  dexamethasone  has  also  been
uggested  to  be  dependent  on  a  distinct  GR  polymorphism
Huizenga  et  al.,  1998a).  Next,  the  timing  of  cortisol  samp-
ing  was  set  at  08:00  h  for  everyone  independent  of  their
ake-up  times  at  the  days  of  saliva  sampling.  And,  as  we
ad  only  one  baseline  sample,  we  were  not  able  to  assess
he  cortisol  awakening  response.  Last,  the  actigraphy  and
ery  low-dose  DST  were  not  administered  in  the  same  week,
e  thus  assessed  the  effect  of  habitual  rhythms  and  sleep
n  the  negative  feedback  control  of  the  HPA  axis  and  not  the
ffect  of  dexamethasone  intake  on  sleep  directly.
In  conclusion,  a  less  stable  24-h  organization,  a  shorter
leep  duration,  and  a  poor  perceived  sleep  quality  were
ssociated  with  the  negative  feedback  control  of  the  HPA
xis,  as  indicated  by  the  difference  in  the  cortisol  concen-
rations  in  saliva  before  and  after  the  intake  of  0.25  mg
f  dexamethasone.  Dexamethasone  cortisol  reactivity  may
elp  to  understand  the  impact  of  circadian  rhythm  and  sleep
isturbances  on  the  stress  system.
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